Migraine and Stroke: A Scoping Review

被引:3
作者
Nathan, Neal [1 ]
Ngo, Angeline [1 ]
Khoromi, Suzan [1 ]
机构
[1] Univ Calif San Diego, Dept Neurosci, 200 W Arbor Dr, San Diego, CA 92103 USA
关键词
migraine; stroke; migrainous infarction; cortical spreading depression; SPREADING DEPRESSION; CARDIOVASCULAR-DISEASE; ISCHEMIC-STROKE; RISK-FACTOR; AURA; TRIPTANS; CGRP; MRI; ERGOTAMINE; BIOMARKERS;
D O I
10.3390/jcm13185380
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An increased risk of ischemic stroke in migraine with aura (MA) has been consistently demonstrated. The pathophysiology of risk factors is not yet well understood. Several mechanisms have been proposed to explain the association between MA and ischemic stroke including decreased focal cerebral blood flow and other phenomena linked with cortical spreading depression (CSD) as well as neurovascular pathology, which appear to play a key role in MA. In addition to genetic predisposition, other classic stroke risk factors such as atrial fibrillation, emboli, migraine-associated vasculopathy, endothelial dysfunction, platelet dysfunction, coagulation pathway abnormalities, and inflammatory factors have been examined and investigated. For further clarification, distinctions have been made between features of migrainous infarctions and non-migrainous infarctions among migraineurs. Furthermore, the association is less clear when considering the mixed results studying the risk of ischemic stroke in migraines without aura (MO) and the risk of hemorrhagic stroke in people with all types of migraine. Translational research is investigating the role of biomarkers which can help identify vascular links between stroke and migraine and lead to further treatment developments. We performed a scoping review of the PubMed database to further characterize and update the clinical connections between migraine and stroke.
引用
收藏
页数:13
相关论文
共 82 条
[1]   Risk of Stroke in Migraineurs Using Triptans. Associations with Age, Sex, Stroke Severity and Subtype [J].
Albieri, Vanna ;
Olsen, Tom Skyhoj ;
Andersen, Klaus Kaae .
EBIOMEDICINE, 2016, 6 :199-205
[2]   Ischemic stroke subtypes and migraine with visual aura in the ARIC study [J].
Androulakis, X. Michelle ;
Kodumuri, Nishanth ;
Giamberardino, Lauren D. ;
Rosamond, Wayne D. ;
Gottesman, Rebecca F. ;
Yim, Eunsil ;
Sen, Souvik .
NEUROLOGY, 2016, 87 (24) :2527-2532
[3]   Potential source of cerebral embolism in migraine with aura - A transcranial Doppler study [J].
Anzola, GP ;
Magoni, M ;
Guindani, M ;
Rozzini, L ;
Dalla Volta, G .
NEUROLOGY, 1999, 52 (08) :1622-1625
[4]   Triptans and CGRP blockade - impact on the cranial vasculature [J].
Benemei, Silvia ;
Cortese, Francesca ;
Labastida-Ramirez, Alejandro ;
Marchese, Francesca ;
Pellesi, Lanfranco ;
Romoli, Michele ;
Vollesen, Anne Luise ;
Lampl, Christian ;
Ashina, Messoud .
JOURNAL OF HEADACHE AND PAIN, 2017, 18
[5]   An update on the blood vessel in migraine [J].
Brennan, K. C. ;
Charles, Andrew .
CURRENT OPINION IN NEUROLOGY, 2010, 23 (03) :266-274
[6]   Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine [J].
Cernuda-Morollon, Eva ;
Larrosa, Davinia ;
Ramon, Cesar ;
Vega, Juan ;
Martinez-Camblor, Pablo ;
Pascual, Julio .
NEUROLOGY, 2013, 81 (14) :1191-1196
[7]   Elevated circulating endothelial-specific microRNAs in migraine patients: A pilot study [J].
Cheng, Chun-Yu ;
Chen, Shih-Pin ;
Liao, Yi-Chu ;
Fuh, Jong-Ling ;
Wang, Yen-Feng ;
Wang, Shuu-Jiun .
CEPHALALGIA, 2018, 38 (09) :1585-1591
[8]   Blood pressure elevation in erenumab-treated patients with migraine: A retrospective real-world experience [J].
Chhabra, Nikita ;
Mead-Harvey, Carolyn ;
Dodoo, Christopher A. ;
Iser, Courtney ;
Taylor, Hallie ;
Chaudhary, Hira ;
Vanood, Aimen ;
Dodick, David W. .
HEADACHE, 2024, 64 (03) :233-242
[9]  
Chiang Chia-Chun, 2024, Handb Clin Neurol, V199, P465, DOI 10.1016/B978-0-12-823357-3.00021-5
[10]   Cortical spreading depression as a site of origin for migraine: Role of CGRP [J].
Close, Liesl N. ;
Eftekhari, Sajedeh ;
Wang, Minyan ;
Charles, Andrew C. ;
Russo, Andrew F. .
CEPHALALGIA, 2019, 39 (03) :428-434